Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2007-02-21

FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc., resulting in labeling updates for the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDERAL LA (Propranolol hydrochloride)

Snippet

SUPPL AP for INDERAL LA (PROPRANOLOL HYDROCHLORIDE)